XPNPEP1 and inflammatory bowel disease: To help unraveling the complexity of the TL1A/DR3 signaling pathway in the course of IBD, in the present study, we demonstrated that DR3 deletion ameliorates disease development by promoting anti-inflammatory processes, which were associated with enrichment of CD25+FoxP3+ cells in SAMP mice.